9 completed, 2 terminated, 1 active not recruiting, 1 unknown. 2 Not applicable, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Janssen Diagnostics, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients Metastatic Breast Cancer, Breast Cancer | Withdrawn | Janssen Diagnostics, LLC | 2016-01-01 | 2015-06-19 | ||
| CEC Count Changes to Support GvHD Diagnosis. Patients undergoing allo-HSCT, who manifest GvHD. - Graft vs Host Disease, Complications of Organ Transplant Stem Cells | Completed | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 50 | 2014-04-01 | 2019-05-29 | |
| Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) Mesenchymal-marker based ferrofluid (c-MET), Epithelial cell adhesion molecule (EpCAM) ferrofluid - Prostate Cancer, Renal Cell Carcinoma | Not applicable | Completed | Duke University | 62 | 2014-03-01 | 2017-08-01 |
| Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index Blood collection - Metastatic Breast Cancer | Completed | Janssen Diagnostics, LLC | 121 | 2013-04-01 | 2017-03-08 | |
| Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer trastuzumab - Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 1317 | 2013-04-01 | 2019-03-13 |
| Circulating Melanoma Cells in Metastatic Patients Treated With Selective BRAF Inhibitors Anti-B-RAF - Metastatic Melanoma | Unknown | Istituto Oncologico Veneto IRCCS | 200 | 2011-12-01 | 2016-10-03 | |
| Isolation of Circulating Tumor Cells Using a Novel EMT-Based Capture Method Mesenchymal-marker based ferrofluid (N-cadherin or O-cadherin based) - Metastatic Progressive Castration-resistant Prostate Cancer, Metastatic Progressive Breast Cancer | Not applicable | Completed | Duke University | 46 | 2011-11-01 | 2018-12-20 |
| Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001 Everolimus, Bevacizumab - Hepatocellular Carcinoma | Phase 2 | Completed | Gerhard Treiber | 33 | 2008-10-01 | 2012-04-30 |
| GeneSearch Breast Lymph Node (BLN) Assay Timing Study GeneSearch™ Breast Lymph Node (BLN) Assay - Breast Cancer | Terminated | Janssen Diagnostics, LLC | 233 | 2007-12-01 | 2016-01-12 | |
| GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study GeneSearch™ Breast Lymph Node (BLN) Assay - Breast Cancer | Terminated | Janssen Diagnostics, LLC | 461 | 2007-12-01 | 2016-01-12 | |
| Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer GeneSearch™ Breast Lymph Node (BLN) Assay - Breast Cancer | Completed | Janssen Diagnostics, LLC | 80 | 2007-10-01 | 2016-01-12 | |
| Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer Blood Sample - Breast Cancer | Completed | M.D. Anderson Cancer Center | 660 | 2005-10-01 | 2012-07-31 | |
| Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial FEC-DocGemzar adjuvant chemotherapy, FEC-Doc adjuvant chemotherapy, Zoledronic acid i.v. 2 years - Breast Neoplasms | Phase 3 | Completed | Ludwig-Maximilians - University of Munich | 3754 | 2005-09-01 | 2014-07-03 |
| Molecular Studies and Clinical Correlations in Human Prostatic Disease Prostate Cancer | Active not recruiting | Memorial Sloan Kettering Cancer Center | 5290 | 1990-04-01 | 2026-03-09 |
Breast Neoplasms (8) · Neoplasm Metastasis (3) · Neoplastic Cells, Circulating (3) · Prostatic Neoplasms (2) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Graft vs Host Disease (1) · Liver Neoplasms (1) · Melanoma (1) · Pancreatic Neoplasms (1) · Stomach Neoplasms (1) · Urinary Bladder Neoplasms (1)
Biological Assay (3) · Blood Specimen Collection (2) · Bevacizumab (1) · Everolimus (1) · Trastuzumab (1)
United States (9) · Germany (3) · Italy (2) · Belgium (1) · Canada (1) · France (1) · United Kingdom (1)
Andrew J Armstrong, MD (2) · Scott U Adams, MS (2) · Alberto Montero, MD (1) · Brigitte Rack, MD (1) · Camillo Almici, M.D. (1) · Christos Sotiriou, MD (1) · Costanza Paoletti, M.D. (1) · Daniel F Hayes, M.D. (1) · Gerhard Treiber, PD Dr. (1) · Harald L Sommer, Prof. Dr. med. (1) · Jean-Yves Pierga, MD (1) · Martine Piccart, MD (1) · Massimo Cristofanilli, MD (1) · Michail Ignatiadis, MD (1) · Paola Zanovello, Phd (1)
PMID 19192962, PMID 26385214, PMID 27289552, PMID 27387743, PMID 27464822, PMID 28892085, PMID 30643152, PMID 30690254, PMID 33097092, PMID 34165508, PMID 42696691
2005 (1), 2009 (1)